Agenus (AGEN) Short Interest Ratio & Short Volume → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free AGEN Stock Alerts $11.12 +0.26 (+2.39%) (As of 01:15 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Agenus Short Interest DataCurrent Short Interest3,240,000 sharesPrevious Short Interest2,590,000 sharesChange Vs. Previous Month+25.10%Dollar Volume Sold Short$39.27 millionShort Interest Ratio4.1 Days to CoverLast Record DateApril 30, 2024Outstanding Shares21,000,000 sharesFloat Size19,280,000 sharesShort Percent of Float16.80%Today's Trading Volume130,497 sharesAverage Trading Volume681,763 sharesToday's Volume Vs. Average19% Short Selling Agenus ? Sign up to receive the latest short interest report for Agenus and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAGEN Short Interest Over TimeAGEN Days to Cover Over TimeAGEN Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Agenus Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,240,000 shares $39.27 million +25.1%16.8%4.1 $12.12 4/15/20242,590,000 shares $16.84 million -94.6%13.0%3.9 $6.50 3/31/202447,720,000 shares $27.68 million +4.3%N/A4.5 $0.58 3/15/202445,750,000 shares $24.71 million +1.2%N/A4.4 $0.54 2/29/202445,190,000 shares $30.28 million +4.6%N/A3.8 $0.67 2/15/202443,200,000 shares $28.24 million -1.5%N/A3.6 $0.65 Get the Latest News and Ratings for AGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Agenus and its competitors with MarketBeat's FREE daily newsletter. 1/31/202443,850,000 shares $29.26 million +4.7%N/A4.1 $0.67 1/15/202441,880,000 shares $26.80 million +5.6%N/A4 $0.64 12/31/202339,660,000 shares $32.83 million -10.0%N/A4.1 $0.83 12/15/202344,080,000 shares $30.49 million +2.4%N/A5 $0.69 11/30/202343,070,000 shares $33.47 million -5.1%N/A6.3 $0.78 11/15/202345,370,000 shares $33.47 million +32.7%N/A8 $0.74 10/31/202334,180,000 shares $27.34 million +12.4%N/A6.6 $0.80 10/15/202330,410,000 shares $31.93 million +8.1%N/A7 $1.05 9/30/202328,130,000 shares $31.79 million -3.8%N/A7.3 $1.13 9/15/202329,250,000 shares $38.32 million -0.3%N/A7.1 $1.31 8/31/202329,350,000 shares $40.50 million +11.5%N/A5.9 $1.38 8/15/202326,320,000 shares $35.53 million +36.2%N/A5 $1.35 7/31/202319,330,000 shares $29.38 million +0.6%N/A3.8 $1.52 7/15/202319,210,000 shares $33.81 million -0.9%N/A3.7 $1.76 6/30/202319,390,000 shares $31.02 million -5.8%N/A3.5 $1.60 6/15/202320,590,000 shares $37.27 million +6.0%N/A3.7 $1.81 5/31/202319,430,000 shares $30.31 million -3.0%N/A3.6 $1.56 5/15/202320,030,000 shares $30.45 million +2.5%N/A3.8 $1.52 4/30/202319,550,000 shares $29.52 million -18.1%N/A3.8 $1.51 4/15/202323,880,000 shares $34.63 million -3.1%N/A4.7 $1.45 3/31/202324,640,000 shares $37.45 million +16.4%N/A5.2 $1.52 3/15/202321,170,000 shares $40.01 million +2.5%N/A4.5 $1.89 2/28/202320,650,000 shares $42.54 million +3.1%N/A5 $2.06 2/15/202320,030,000 shares $43.26 million -9.5%N/A5.1 $2.16 1/31/202322,140,000 shares $57.79 million +9.0%N/A5 $2.61 1/15/202320,320,000 shares $59.94 million +4.4%N/A4.6 $2.95 12/30/202219,460,000 shares $46.70 million +2.5%N/A4.5 $2.40 12/15/202218,990,000 shares $46.34 million -4.7%N/A4 $2.44 11/30/202219,930,000 shares $53.81 million -11.4%N/A4.2 $2.70 11/15/202222,500,000 shares $71.33 million +18.5%N/A4.7 $3.17 10/31/202218,990,000 shares $47.66 million +2.1%N/A4.3 $2.51 10/15/202218,600,000 shares $45.38 million +9.9%N/A4.1 $2.44 9/30/202216,920,000 shares $34.69 million +5.0%N/A3.7 $2.05 9/15/202216,120,000 shares $40.62 million -4.4%N/A3.3 $2.52He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs 8/31/202216,860,000 shares $45.52 million -5.0%N/A3.3 $2.70 8/15/202217,740,000 shares $55.70 million +7.5%N/A3.5 $3.14 7/31/202216,510,000 shares $42.60 million +9.6%N/A3.2 $2.58 7/15/202215,070,000 shares $43.40 million -3.3%N/A3 $2.88 6/30/202215,590,000 shares $30.24 million +11.2%N/A3.2 $1.94 6/15/202214,020,000 shares $19.49 million -6.7%14.2%3.2 $1.39 5/31/202215,030,000 shares $25.10 million -10.9%N/A3.5 $1.67 5/15/202216,860,000 shares $27.48 million -19.5%N/A3.7 $1.63 4/30/202220,930,000 shares $38.72 million +1.2%N/A4.9 $1.85 4/15/202220,690,000 shares $48.41 million +3.4%N/A4.9 $2.34 3/31/202220,010,000 shares $49.22 million -23.0%N/A4.7 $2.46 3/15/202226,000,000 shares $69.16 million -18.4%N/A6.4 $2.66 2/28/202231,870,000 shares $86.05 million +14.7%N/A7.6 $2.70 2/15/202227,790,000 shares $71.14 million +5.1%N/A6.6 $2.56 1/31/202226,440,000 shares $72.97 million +4.1%N/A6.3 $2.76 1/15/202225,390,000 shares $77.44 million +3.1%N/A6 $3.05 12/31/202124,620,000 shares $79.28 million +31.9%N/A5.6 $3.22 12/15/202118,670,000 shares $61.80 million +8.1%N/A4.2 $3.31 11/30/202117,270,000 shares $54.40 million +13.2%7.8%4.2 $3.15 11/15/202115,260,000 shares $55.70 million -11.1%6.9%3.6 $3.65 10/29/202117,170,000 shares $65.93 million +14.2%8.6%4.1 $3.84 10/15/202115,040,000 shares $79.86 million -29.3%7.5%3.8 $5.31 9/30/202121,270,000 shares $111.67 million -0.4%10.6%6 $5.25 9/15/202121,360,000 shares $114.92 million -6.1%10.7%6.2 $5.38 8/31/202122,740,000 shares $140.31 million +1.6%11.4%6.6 $6.17 8/13/202122,380,000 shares $137.64 million -0.2%11.3%6.7 $6.15 7/30/202122,430,000 shares $116.19 million -0.7%11.9%4.6 $5.18 7/15/202122,580,000 shares $121.93 million -13.1%11.9%4.6 $5.40 6/30/202125,990,000 shares $142.69 million -6.3%13.7%5.1 $5.49 6/15/202127,740,000 shares $139.81 million -2.1%14.7%5.2 $5.04 5/28/202128,320,000 shares $120.64 million +3.7%15.0%5.4 $4.26 5/14/202127,310,000 shares $82.75 million -0.3%N/A5.3 $3.03 4/30/202127,380,000 shares $84.60 million -0.2%N/A8.1 $3.09 4/15/202127,430,000 shares $73.79 million +1.5%N/A6.9 $2.69 3/31/202127,020,000 shares $72.95 million +12.4%N/A7.4 $2.70 3/15/202124,040,000 shares $79.57 million -0.8%N/A7 $3.31 2/26/202124,230,000 shares $99.10 million +1.8%N/A8 $4.09 2/12/202123,810,000 shares $112.15 million -4.6%N/A8.4 $4.71 1/29/202124,950,000 shares $91.57 million 0.0%N/A9.1 $3.67 1/15/202124,960,000 shares $85.36 million +1.8%N/A11.4 $3.42 12/31/202024,530,000 shares $80.70 million +12.9%N/A12 $3.29 12/15/202021,720,000 shares $79.71 million -3.0%N/A10.9 $3.67 11/30/202022,390,000 shares $83.07 million -3.7%N/A8.7 $3.71 11/15/202023,240,000 shares $88.08 million -2.1%N/A9.5 $3.79 10/30/202023,730,000 shares $88.28 million +1.5%N/A9.5 $3.72 10/15/202023,380,000 shares $95.86 million +1.0%N/A8.8 $4.10 9/30/202023,150,000 shares $92.60 million +0.4%N/A8.3 $4.00 9/15/202023,050,000 shares $115.48 million -1.5%N/A7.8 $5.01 8/31/202023,400,000 shares $102.02 million -3.6%N/A8.5 $4.36 8/14/202024,280,000 shares $90.08 million +2.6%N/A7.8 $3.71He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs 7/31/202023,660,000 shares $71.93 million +12.9%N/A7.4 $3.04 7/15/202020,950,000 shares $77.31 million +2.2%N/A6.7 $3.69 6/30/202020,510,000 shares $80.60 million +20.9%N/A6.6 $3.93 6/15/202016,960,000 shares $61.23 million -1.5%N/A5.5 $3.61 5/29/202017,210,000 shares $64.19 million +1.8%N/A5.3 $3.73 5/15/202016,910,000 shares $38.72 million +6.0%N/A6.1 $2.29 4/30/202015,960,000 shares $42.53 million +4.9%N/A6.2 $2.67 4/15/202015,210,000 shares $39.55 million +8.7%11.7%6.3 $2.60 3/31/202013,990,000 shares $39.03 million +9.6%10.8%6.4 $2.79 3/13/202012,766,700 shares $31.92 million -2.0%12.1%2.9 $2.50 2/28/202013,020,000 shares $25.91 million +7.2%12.4%7.6 $1.99 2/14/202012,150,000 shares $34.14 million +3.7%11.5%9.4 $2.81 1/31/202011,720,000 shares $34.57 million +5.0%11.1%8.7 $2.95 1/15/202011,160,000 shares $42.30 million -4.9%10.6%8.5 $3.79 12/31/201911,730,000 shares $44.34 million +15.3%11.2%9.5 $3.78 AGEN Short Interest - Frequently Asked Questions What is Agenus' current short interest? Short interest is the volume of Agenus shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 3,240,000 shares of AGEN short. 16.80% of Agenus' shares are currently sold short. Learn More on Agenus' current short interest. What is a good short interest ratio for Agenus? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGEN shares currently have a short interest ratio of 4.0. Learn More on Agenus's short interest ratio. Which institutional investors are shorting Agenus? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Agenus: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Agenus? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.80% of Agenus' floating shares are currently sold short. Is Agenus' short interest increasing or decreasing? Agenus saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 3,240,000 shares, an increase of 25.1% from the previous total of 2,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Agenus' float size? Agenus currently has issued a total of 21,000,000 shares. Some of Agenus' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Agenus currently has a public float of 19,280,000 shares. How does Agenus' short interest compare to its competitors? 16.80% of Agenus' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Agenus: Sangamo Therapeutics, Inc. (6.92%), Curis, Inc. (1.14%), Zura Bio Limited (3.07%), Compass Therapeutics, Inc. (1.90%), Acumen Pharmaceuticals, Inc. (2.09%), Innate Pharma S.A. (0.10%), Opthea Limited (0.22%), Coherus BioSciences, Inc. (18.91%), INmune Bio, Inc. (13.54%), Century Therapeutics, Inc. (5.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Agenus stock? Short selling AGEN is an investing strategy that aims to generate trading profit from Agenus as its price is falling. AGEN shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Agenus? A short squeeze for Agenus occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AGEN, which in turn drives the price of the stock up even further. How often is Agenus' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGEN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Sangamo Therapeutics Short Interest Curis Short Interest Zura Bio Short Interest Compass Therapeutics Short Interest Acumen Pharmaceuticals Short Interest Innate Pharma Short Interest Opthea Short Interest Coherus BioSciences Short Interest INmune Bio Short Interest Century Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AGEN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestNew Options need New Trading StrategiesNetpicks